Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 13, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals on April 11, 2006, at a price of GBP 14.93 per share through the Company's ShareReward Plan. The transactions involved:
- Mr R Bondy: Acquired 8 shares (personal contribution) and 8 shares (Company matching contribution).
- Mr J S Heslop: Acquired 8 shares (personal contribution) and 8 shares (Company matching contribution).
- Mr A P Witty: Acquired 8 shares (personal contribution) and 8 shares (Company matching contribution).
- Mrs J V Younger: Acquired 8 shares (personal contribution) and 8 shares (Company matching contribution).
These acquisitions were made under the partnership and matching elements of the Plan entered into on October 5, 2001.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of specific share transactions in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Key Facts for Investor Verification
- Transaction Date: April 11, 2006.
- Share Price: GBP 14.93 per Ordinary Share.
- Participants: Mr R Bondy, Mr J S Heslop, Mr A P Witty, and Mrs J V Younger.
- Total Shares Acquired per Participant: 16 shares (8 personal + 8 matched).
- Notification Date: April 12, 2006.
- Reporting Date: April 13, 2006.